← The Wire
RLYBNasdaq
Rallybio Corp
Pharmaceutical Preparations · DE · CIK 1739410
Develops and commercializes life-transforming therapies for severe and rare diseases
red 8-K · 90d
$92M
Market cap
$16.06
Last close
+0.4%
1D
+0.8%
5D
31K
Volume
Price · last 39 sessions+13.7%
May 4L $14.00 · H $16.87Jun 29
92
Total filings
Jun 1, 2026
Last filing
12/31
Fiscal year end
10-Q10-QMay 13, 202610-Q10-QNov 6, 202510-Q10-QAug 7, 202510-Q10-QMay 8, 202510-Q10-QNov 7, 202410-Q10-QAug 8, 202410-Q10-QMay 9, 202410-Q10-QNov 9, 202310-Q10-QAug 8, 202310-Q10-QMay 9, 202310-Q10-QNov 7, 202210-Q10-QAug 8, 202210-Q10-QMay 10, 202210-Q10-QNov 10, 202110-Q10-QSep 9, 2021
Insider Activity
In the 90 days to Feb 23, 2026: 1 sold $4K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 23, 2026 | Lieber Jonathan IChief Financial Officer | Sell | 789 | $5.06 | $4K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance